Adjunctive Prednisolone in the Treatment of Effusive Tuberculous Pericarditis in HIV Seropositive Patients - Adjunctive Prednisolone in the Treatment of Effusive Tuberculous Pericarditis in HIV Seropositive Patients

Description:

The goal of this randomized, double-blind, placebo-controlled trial was to evaluate use of adjunctive prednisolone on morbidity and mortality among HIV positive patients with effusive tuberculous pericarditis.